Publication | Open Access
Improvement of Severe Fatigue Following Nuclease Therapy in Patients With Primary Sjögren’s Syndrome: A Randomized Clinical Trial
58
Citations
22
References
2020
Year
Administration of RSLV-132 improved severe fatigue, as determined by 4 independent patient-reported measures of fatigue, in patients with primary SS.
| Year | Citations | |
|---|---|---|
Page 1
Page 1